Funding for Cures Bill Remains Sticking Point for Health Groups
From the article:
The Cures bill will fund some prevention efforts, said Lynne Weil, a spokeswoman for Representative Diana DeGette, a Democrat from Colorado who helped shape the House’s original version of the measure.
“If you look at the projects that the fund was initially slated to cover, some of them are a little duplicative with existing prevention efforts,” Rachel Sachs, an associate professor at the Washington University School of Law in St. Louis, said in an interview. “Others, it may be that they need less funding.”
Read the full article here.bioethics fda health care reform health law policy pharmaceuticals rachel sachs regulation